Hjem › Amyloidose › Massachusetts › Boston
Amyloidose kliniske forsøg i Boston, MA
11 studier for Amyloidose søger deltagere på steder i og omkring Boston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RekruttererObservationsstudie
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RekruttererFase 3
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
RekruttererFase 3
- Clinical Trial Site, Boston
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RekruttererObservationsstudie
- Clinical Trial Site, Boston
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Rekrutterer
- Massachusetts General Hospital, Boston
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RekruttererFase 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RekruttererFase 3
- Brigham and Women's Hospital, Boston
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RekruttererFase 1/2
- Research Site, Boston
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
RekruttererFase 1/2
- Boston Medical Center /ID# 255066, Boston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RekruttererFase 3
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
Molecular Imaging of Primary Amyloid Cardiomyopathy
Rekrutterer
- Brigham and Womens' Hospital, Boston
Amyloidose forsøg i andre byer
- Rochester, MN10 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Philadelphia, PA7 studier
- Houston, TX6 studier
- Baltimore, MD6 studier
- Durham, NC6 studier
- Portland, OR6 studier
- St. Louis, MO6 studier
- San Diego, CA5 studier
- Cleveland, OH5 studier
- Chicago, IL5 studier
Andre studier i Boston
- Brystkræft111 studier
- Ikke-småcellet lungecancer90 studier
- Kræft (alle typer)86 studier
- Colorektal kræft63 studier
- Metastatisk cancer63 studier
- Lungecancer62 studier
- Ægstockræft61 studier
- Prostatakræft59 studier
- Depression52 studier
- Livmoderslimhindekræft50 studier
- Hjertesvigt44 studier
- Akut myeloid leukæmi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.